Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Finerenone”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07583173
What this trial is testing

Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients

Who this might be right for
Heart Failure
China National Center for Cardiovascular Diseases 104
Large-scale testing (Phase 3)Looking for participantsNCT05457283
What this trial is testing

Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuriaChildren
Bayer 100
Large-scale testing (Phase 3)Looking for participantsNCT06033950
What this trial is testing

Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure
Colorado Prevention Center 2,600
Testing effectiveness (Phase 2)Study completedNCT01968668
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Who this might be right for
Diabetic Nephropathies
Bayer 96
Testing effectiveness (Phase 2)Study completedNCT01345656
What this trial is testing

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Who this might be right for
Heart Failure
Bayer 457
Post-approval studies (Phase 4)Study completedNCT06381323
What this trial is testing

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismFinerenoneMineralocorticoid Receptor Antagonist
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 55
Not applicableStudy completedNCT05526157
What this trial is testing

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT07442448
What this trial is testing

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

Who this might be right for
Heart Failure and Preserved Ejection FractionHeart FailureHeart Failure and Mildly Reduced Ejection Fraction
Cathay General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT05254002
What this trial is testing

Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 1,664
Large-scale testing (Phase 3)Study completedNCT02545049
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bayer 7,352
Not applicableStudy completedNCT04795726
What this trial is testing

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)

Who this might be right for
Diabetic Retinopathy
Bayer 70
Post-approval studies (Phase 4)Looking for participantsNCT07315191
What this trial is testing

Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

Who this might be right for
Henoch Schönlein Purpura Nephritis
Capital Institute of Pediatrics, China 116
Not applicableStudy completedNCT05640180
What this trial is testing

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Bayer 17,847
Not applicableActive Not RecruitingNCT06763146
What this trial is testing

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 1,200
Early research (Phase 1)Study completedNCT04881994
What this trial is testing

Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureDiabetic Nephropathy
Bayer 27
Early research (Phase 1)Study completedNCT07116512
What this trial is testing

Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants

Who this might be right for
Heart Failure With Left Ventricular Ejection Fraction Greater Than or Equal to 40 Per CentHealthy Volunteers
Bayer 60
Testing effectiveness (Phase 2)Looking for participantsNCT06906081
What this trial is testing

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Who this might be right for
Cardiovascular Autonomic NeuropathyType 2 DiabetesDiabetic Neuropathies
Peter Rossing 100
Large-scale testing (Phase 3)Study completedNCT02540993
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Bayer 5,734
Large-scale testing (Phase 3)Not Yet RecruitingNCT06580288
What this trial is testing

Effect of Finerenone in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Zhejiang University 120
Not applicableNot Yet RecruitingNCT07554469
What this trial is testing

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 500
Load More Results